Regulations.gov document
Reference 14 Quality of Pharmaceutical Advertisements in Medical Journals: A Systematic…
Supporting & Related Material · FDA-2018-N-3163 · posted Jul 23, 2019
Key facts
| Document ID | FDA-2018-N-3163-0020 |
|---|---|
| Title | Reference 14 Quality of Pharmaceutical Advertisements in Medical Journals: A Systematic Review re: Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Physician Interpretation of Information About Prescription Drugs in Scientific Publications Versus Promotional Pieces |
| Document type | Supporting & Related Material |
| Subtype | Background Material |
| Agency | FDA |
| Docket | FDA-2018-N-3163 |
| Posted | Jul 23, 2019 |
At a glance
- 1–9 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: